Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 39 presents the latest on a variety of topics, with new chapters in this volume covering Central nervous system stimulants and drugs that suppress appetite, Antidepressant drugs, Lithium, Drugs of abuse, Hypnotics and sedatives, Antipsychotic Drugs, Antiepileptic Drugs, Opioid analgesics and narcotic antagonists, Anti-inflammatory and antipyretic analgesics and drugs used in gout, General anesthetics and therapeutic gases, Local anesthetics, Neuromuscular blocking agents and skeletal muscle relaxants, and more.
First published in 1977, and continually published as a yearly update, this series provides clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing their expertise each year.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. v 6. Preface - p. xvii 7. Special Reviews in SEDA 39 - p. xix 8. Table of Essays, Annuals 1–38 - p. xxi 9. Abbreviations - p. xxiii 10. ADRs, ADEs and SEDs: A Bird's Eye View - p. xxvii 11. Chapter 1: Central Nervous System Stimulants and Drugs That Suppress Appetite - p. xlii 12. Chapter 2: Antidepressants - p. 8 13. Chapter 3: Lithium - p. 21 14. Chapter 4: Drugs of Abuse - p. 30 15. Chapter 5: Hypnotics and Sedatives - p. 55 16. Chapter 6: Antipsychotic Drugs - p. 63 17. Chapter 7: Antiepileptics - p. 90 18. Chapter 8: Opioid Analgesics and Narcotic Antagonists - p. 106 19. Chapter 9: General Anesthetics and Therapeutic Gases - p. 110 20. Chapter 10: Local Anesthetics - p. 121 21. Chapter 11: Drugs That Affect Autonomic Functions or the Extrapyramidal System - p. 132 22. Chapter 12: Dermatological Drugs, Topical Agents, and Cosmetics - p. 144 23. Chapter 13: Antihistamines (H1 Receptor Antagonists) - p. 155 24. Chapter 14: Drugs that Act on the Respiratory Tract - p. 159 25. Chapter 15: Positive Inotropic Drugs and Drugs Used in Dysrhythmias - p. 171 26. Chapter 16: Drugs Acting on the Cerebral and Peripheral Circulations - p. 178 27. Chapter 17: Antihypertensive Drugs - p. 181 28. Chapter 18: Diuretics - p. 187 29. Chapter 19: Metals and Metal Antagonists - p. 195 30. Chapter 20: Antiseptic Drugs and Disinfectants - p. 208 31. Chapter 21: Beta-Lactams and Tetracyclines - p. 215 32. Chapter 22: Miscellaneous Antibacterial Drugs - p. 227 33. Chapter 23: Antifungal Drugs - p. 243 34. Chapter 24: Antiprotozoal Drugs - p. 258 35. Chapter 25: Antiviral Drugs - p. 267 36. Chapter 26: Drugs Used in TB and Leprosy - p. 282 37. Chapter 27: Antihelminthic Drugs - p. 293 38. Chapter 28: Vaccines - p. 300 39. Chapter 29: Blood, Blood Components, Plasma, and Plasma Products - p. 330 40. Chapter 30: Vitamins, Amino Acids and Drugs and Formulations Used in Nutrition - p. 343 41. Chapter 31: Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis - p. 358 42. Chapter 32: Gastrointestinal Drugs - p. 372 43. Chapter 33: Drugs That Act on the Immune System: Immunosuppressive and Immunostimulatory Drugs - p. 387 44. Chapter 34: Corticotrophins, Corticosteroids, and Prostaglandins - p. 406 45. Chapter 35: Sex Hormones and Related Compounds, Including Hormonal Contraceptives - p. 415 46. Chapter 36: Thyroid Hormones, Iodine and Iodides, and Antithyroid Drugs - p. 426 47. Chapter 37: Insulin and Other Hypoglycemic Drugs - p. 433 48. Chapter 38: Miscellaneous Hormones - p. 446 49. Chapter 39: Drugs That Affect Lipid Metabolism - p. 455 50. Chapter 40: Cytostatic Agents: Monoclonal Antibodies Utilized in the Treatment of Solid Malignancies - p. 463 51. Chapter 41: Radiological Contrast Agents - p. 482 52. Chapter 42: Drugs Used in Ocular Treatment - p. 489 53. Chapter 43: Safety of Complementary and Alternative Medicine (CAM) Treatments and Practices - p. 501 54. Reviewers - p. 513 55. Index of Drugs - p. 515 56. Index of Drug-Drug Interactions - p. 523 57. Index of Adverse Effects and Adverse Reactions - p. 525
Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 39 presents the latest on a variety of topics, with new chapters in this volume covering Central nervous system stimulants and drugs that suppress appetite, Antidepressant drugs, Lithium, Drugs of abuse, Hypnotics and sedatives, Antipsychotic Drugs, Antiepileptic Drugs, Opioid analgesics and narcotic antagonists, Anti-inflammatory and antipyretic analgesics and drugs used in gout, General anesthetics and therapeutic gases, Local anesthetics, Neuromuscular blocking agents and skeletal muscle relaxants, and more.
First published in 1977, and continually published as a yearly update, this series provides clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing their expertise each year.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. v 6. Preface - p. xvii 7. Special Reviews in SEDA 39 - p. xix 8. Table of Essays, Annuals 1–38 - p. xxi 9. Abbreviations - p. xxiii 10. ADRs, ADEs and SEDs: A Bird's Eye View - p. xxvii 11. Chapter 1: Central Nervous System Stimulants and Drugs That Suppress Appetite - p. xlii 12. Chapter 2: Antidepressants - p. 8 13. Chapter 3: Lithium - p. 21 14. Chapter 4: Drugs of Abuse - p. 30 15. Chapter 5: Hypnotics and Sedatives - p. 55 16. Chapter 6: Antipsychotic Drugs - p. 63 17. Chapter 7: Antiepileptics - p. 90 18. Chapter 8: Opioid Analgesics and Narcotic Antagonists - p. 106 19. Chapter 9: General Anesthetics and Therapeutic Gases - p. 110 20. Chapter 10: Local Anesthetics - p. 121 21. Chapter 11: Drugs That Affect Autonomic Functions or the Extrapyramidal System - p. 132 22. Chapter 12: Dermatological Drugs, Topical Agents, and Cosmetics - p. 144 23. Chapter 13: Antihistamines (H1 Receptor Antagonists) - p. 155 24. Chapter 14: Drugs that Act on the Respiratory Tract - p. 159 25. Chapter 15: Positive Inotropic Drugs and Drugs Used in Dysrhythmias - p. 171 26. Chapter 16: Drugs Acting on the Cerebral and Peripheral Circulations - p. 178 27. Chapter 17: Antihypertensive Drugs - p. 181 28. Chapter 18: Diuretics - p. 187 29. Chapter 19: Metals and Metal Antagonists - p. 195 30. Chapter 20: Antiseptic Drugs and Disinfectants - p. 208 31. Chapter 21: Beta-Lactams and Tetracyclines - p. 215 32. Chapter 22: Miscellaneous Antibacterial Drugs - p. 227 33. Chapter 23: Antifungal Drugs - p. 243 34. Chapter 24: Antiprotozoal Drugs - p. 258 35. Chapter 25: Antiviral Drugs - p. 267 36. Chapter 26: Drugs Used in TB and Leprosy - p. 282 37. Chapter 27: Antihelminthic Drugs - p. 293 38. Chapter 28: Vaccines - p. 300 39. Chapter 29: Blood, Blood Components, Plasma, and Plasma Products - p. 330 40. Chapter 30: Vitamins, Amino Acids and Drugs and Formulations Used in Nutrition - p. 343 41. Chapter 31: Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis - p. 358 42. Chapter 32: Gastrointestinal Drugs - p. 372 43. Chapter 33: Drugs That Act on the Immune System: Immunosuppressive and Immunostimulatory Drugs - p. 387 44. Chapter 34: Corticotrophins, Corticosteroids, and Prostaglandins - p. 406 45. Chapter 35: Sex Hormones and Related Compounds, Including Hormonal Contraceptives - p. 415 46. Chapter 36: Thyroid Hormones, Iodine and Iodides, and Antithyroid Drugs - p. 426 47. Chapter 37: Insulin and Other Hypoglycemic Drugs - p. 433 48. Chapter 38: Miscellaneous Hormones - p. 446 49. Chapter 39: Drugs That Affect Lipid Metabolism - p. 455 50. Chapter 40: Cytostatic Agents: Monoclonal Antibodies Utilized in the Treatment of Solid Malignancies - p. 463 51. Chapter 41: Radiological Contrast Agents - p. 482 52. Chapter 42: Drugs Used in Ocular Treatment - p. 489 53. Chapter 43: Safety of Complementary and Alternative Medicine (CAM) Treatments and Practices - p. 501 54. Reviewers - p. 513 55. Index of Drugs - p. 515 56. Index of Drug-Drug Interactions - p. 523 57. Index of Adverse Effects and Adverse Reactions - p. 525
